SHE: 000661

Company Drug

Changchun High & New Technology Industries to Launch GenSci125 Phase I Trial in US

Fineline Cube Jan 17, 2024

Changchun High & New Technology Industries (Group) Inc., (SHE: 000661), a leading Chinese pharmaceutical company,...

Company

Changchun High & New Technology to Transfer 7.42% Stake to Ex-Wife in Divorce Settlement

Fineline Cube Jan 12, 2024

Changchun High & New Technology Industries (Group) Inc., (SHE: 000661) has announced plans to transfer...

Drug

Changchun High & New Technology’s Jinnamab Approved for AOSD Clinical Study by US FDA

Fineline Cube Jun 15, 2022

China-based Changchun High & New Technology Industries (Group) Inc. (SHE: 000661) has announced that it...

Company Drug

Wenda Pharmaceutical Secures NMPA Breakthrough Therapy Designation for NHWD-870 in Rare NUT Carcinoma

Company Drug

European Commission Approves Bristol Myers Squibb’s Sotyktu for Psoriatic Arthritis Following FDA Clearance

Company Deals

CureGene Pharmaceutical Secures RMB 300 Million Series C to Advance Global Clinical Pipeline

Company Drug

Keymed Biosciences Secures NMPA Breakthrough Therapy Designation for CM336 in AL Amyloidosis